Skip to main content
×
Home
    • Aa
    • Aa

COST-EFFECTIVENESS OF AN ADVANCE NOTIFICATION LETTER TO INCREASE COLORECTAL CANCER SCREENING

  • Paula Cronin (a1), Stephen Goodall (a1), Trevor Lockett (a2), Christine M. O'Keefe (a3), Richard Norman (a1) and Jody Church (a1)...
Abstract

Objectives: The aim of this study is to evaluate the cost-effectiveness of a patient-direct mailed advance notification letter on participants of a National Bowel Cancer Screening Program (NBCSP) in Australia, which was launched in August 2006 and offers free fecal occult blood testing to all Australians turning 50, 55, or 65 years of age in any given year.

Methods: This study followed a hypothetical cohort of 50-year-old, 55-year-old, and 65-year-old patients undergoing fecal occult blood test (FOBT) screening through a decision analytic Markov model. The intervention compared two strategies: (i) advance letter, NBCSP, and FOBT compared with (ii) NBCSP and FOBT. The main outcome measures were life-years gained (LYG), quality-adjusted life-years (QALYs) gained and incremental cost-effectiveness ratio.

Results: An advance notification screening letter would yield an additional 54 per 100,000 colorectal cancer deaths avoided compared with no letter. The estimated cost-effectiveness was $3,976 per LYG and $6,976 per QALY gained.

Conclusions: An advance notification letter in the NBCSP may have a significant impact on LYG and cancer deaths avoided. It is cost-effective and offers a feasible strategy that could be rolled out across other screening program at an acceptable cost.

Copyright
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

3.JS Mandel , TR Church , JH Bond , et al.The effect of fecel occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:16031607.

4.G Salkeld , G Young , L Irwig , M Haas , P Glasziou . Cost-effectiveness analysis of screening by faecal occult blood testing for colorectal cancer in Australia. Aust N Z J Public Health. 1996;20:138143.

8.SR Cole , A Smith , C Wilson , et al.An advance notification letter increases participation in colorectal cancer screening. J Med Screen. 2007;14:7375.

9.JK Lee , EJ Groessl , TG Ganiats , SB Ho . Cost-effectiveness of a mailed educational reminder to increase colorectal cancer screening. BMC Gastroenterol. 2011;11:93.

10.TD Sequist , C Franz , JZ Ayanian . Cost-effectiveness of patient mailings to promote colorectal cancer screening. Med Care. 2010;48:553557.

11.BA O'Leary , JK Olynyk , AM Neville , CF Platell . Cost-effectiveness of colorectal cancer screening: Comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy. J Gastroenterol Hepatol. 2004;19:3847.

13.DA Lieberman , DG Weiss , JH Bond , et al.Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med. 2000;343:162168.

15.TJ Mapp , JD Hardcastle , SM Moss , MH Robinson . Survival of patients with colorectal cancer diagnosed in a randomized controlled trial of faecal occult blood screening. Br J Surg. 1999;86:12861291.

16.MH Robinson , JD Hardcastle , SM Moss , et al.The risks of screening: Data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut. 1999;45:588592.

19.F Loeve , ML Brown , R Boer , et al.Endoscopic colorectal cancer screening: A cost-saving analysis. J Natl Cancer Inst. 2000;92:557563.

20.H Brenner , L Altenhofen , A Katalinic , I Lansdorp-Vogelaar , M Hoffmeister . Sojourn time of preclinical colorectal cancer by sex and age: Estimates from the German National Screening Colonoscopy Database. Am J Epidemiol. 2011;174:11401146.

22.MA Parker , MH Robinson , JH Scholefield , JD Hardcastle . Psychiatric morbidity and screening for colorectal cancer. J Med Screen. 2002;9:710.

37.A Smith , GP Young , SR Cole , P Bampton . Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer. 2006;107:21522159.

28.B George , A Harris , A Mitchell . Cost-effectiveness analysis and the consistency of decision making: Evidence from pharmaceutical reimbursement in Australia (1991 to 1996). Pharmacoeconomics. 2001;19:11031109.

29.JM Lane , E Chow , GP Young , N Good . Immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology. 2010;139:19181926.

30.K Howard , G Salkeld , L Irwig , BA Adelstein . High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen. 2005;12:96102.

31.J King , G Fairbrother , C Thompson , DL Morris . Colorectal cancer screening: Optimal compliance with postal faecal occult blood test. Aust N Z J Surg. 1992;62:714719.

32.TN Chirikos , LK Chistman , BS Seft Hunter , MD Roetzheim . Cost-effectiveness of an intervention to increase cancer screening in primary care settings. Prev Med. 2004;39:230238.

33.WS Atkin , BC Morson , J Cuzick . Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med. 1992;326:658662.

40.JA McLeish , VJ Thursfield , GG Giles . Survival from colorectal cancer in Victoria: 10-year follow up of the 1987 management survey. ANZ J Surg. 2002;72:352356.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Journal of Technology Assessment in Health Care
  • ISSN: 0266-4623
  • EISSN: 1471-6348
  • URL: /core/journals/international-journal-of-technology-assessment-in-health-care
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Type Description Title
WORD
Supplementary Materials

Cronin Supplementary Material
Appendix

 Word (201 KB)
201 KB

Metrics

Altmetric attention score